How can academic discoveries be advanced to a commercial setting more efficiently? How can the university – industry bridge be strengthened and how can investors engage to advance the growing portfolio of investment opportunities emerging from the Nordic SPARK initiative?
Welcome to a session where the Directors of the Nordic SPARK Programmes will discuss these questions with academic innovators, called SPARKees, investors and mentors.
Two SPARKees from UiO:Life Science's innovation programme SPARK Norway are among the panelists:
Esmaeil Dorraji: CAR-T for p95HER2-positive breast cancer patients resistant to antibody treatments targeting HER2